A dose ranging study of 2 different formulations of 15-valent pneumococcal conjugate vaccine (PCV15) in healthy infants
Background: Two new formulations of an investigational 15-valent pneumococcal conjugate vaccine (PCV15-A and PCV15-B) were developed using 2 different protein-polysaccharide conjugation processes and evaluated in separate phase I/II studies (NCT02037984 [V114-004] and NCT02531373 [V114-005]) to asse...
Na minha lista:
| Principais autores: | , , , , , , , , , , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Taylor & Francis Group
2019-03-01
|
| Serier: | Human Vaccines & Immunotherapeutics |
| Fag: | |
| Online adgang: | http://dx.doi.org/10.1080/21645515.2019.1568159 |
| Tags: |
Ingen Tags, Vær først til at tagge denne postø!
|